Minnesota Office of Cannabis Management denies petition to add inhalers, flower and concentrates to medical program
The Office of Cannabis Management in Minneapolis will not introduce new delivery methods to the medical cannabis program in 2025. They evaluated petitions for dry powder inhalation, infused flower, and concentrates based on scientific evidence and health impacts. Current limitations on cannabis research influenced their decision.